Anaplastic lymphoma kinase (ALK) was initially described as a fusion partner of nucleophosmin (NPM) in the NPM-ALK translocation in a cell line derived from a patient with anaplastic large cell lymphoma (ALCL) (1). Here, ALK is linked to anaplastic large cell lymphoma.